Press releases

With the indication, patients receiving the stent systems may safely undergo Magnetic Resonance Imaging (MRI) examination immediately following implantation.

Precision™ Spinal Cord Stimulation (SCS) System is a powerful new technology that provides many chronic pain sufferers a treatment option that is comfortable, long lasting and effective.

Company no longer markets or sells the NIR stent; findings will not affect Boston Scientific's ability to sell its market-leading TAXUS stent systems.

Company's Quincy Distribution Center approved as a sterilization site for its Cutting Balloon™ microsurgical dilatation device product line.

Company recognized for its achievements in lean manufacturing at its Minnesota facility

A live webcast and replay of the March 15th session will be available. Learn how to tune in.

Trial is designed to analyze "real-world" outcomes for patients with gastroesophageal reflux disease (GERD).

Johnson & Johnson trial results add to the extensive body of clinical evidence reinforcing the safety profile of Company’s TAXUS system.

Nine-month study data presented at the annual American College of Cardiology scientific session in Orlando.

(March 4, 2005) -- Boston Scientific Corporation (NYSE:BSX) today announced that it has completed its acquisition of Advanced Stent Technologies, Inc. (AST) of Pleasanton, California, for an...